Resources

1 Resources for

biotechnology watcher

  • Subscribe to this listing via:
  • RSS
  • Email

BNET Resources

Generics Threaten Drugmaker Cephalon's Success
Biotechnology watchers are measuring success at Cephalon on how quickly the drugmaker can convert patients on its soon-to-go generic blockbuster Provigil to regular users of its narcoleptic successor Nuvigil. As Jim Edwards at BNET Pharma astutely pointed out exactly one year ago, however, competition also threatens to derail...
Tags: Cephalon Inc., Biotechnology Watcher, Provigil, Nuvigil, Sales Strategy, Sales Force Management, Sales, David Phillips
Blog posts 2009-09-21
  • << Previous
  • page 1 of 1
  • Next >>
advertisement
advertisement